<?xml version="1.0" encoding="UTF-8"?>
<p>Twenty-six (49%) patients were admitted. The median (IQR) duration of hospitalization was 4 days (1–9). Four (7.5%) patients required ICU admission and two (4%) died. Among the PLWH admitted (
 <italic>n</italic> = 26, 49%), all but two received any specific COVID-19 therapy: 21 received triple therapy with a combination of lopinavir/ritonavir, azithromycin, and hydroxychloroquine, and five received dual therapy with a combination of two of the previous three drugs. Two (8%) individuals also received IFN-1β, seven (28%) systemic glucocorticoids, or eight (32%) tociluzimab. Mechanical ventilation was used in two patients and extracorporeal membrane oxygenation in one patient. Of the PLWH not admitted to hospital (
 <italic>n</italic> = 27, 51%), only one received specific COVID-19 treatment (azithromycin and hydroxychloroquine) and none switched their antiretroviral regimen.
</p>
